Literature DB >> 7069473

Observer variability in grading patients with subarachnoid hemorrhage.

K W Lindsay, G Teasdale, R P Knill-Jones, L Murray.   

Abstract

The management of individual patients with subarachnoid hemorrhage depends greatly on assessment of the patient's clinical condition. Difficulty in applying current grading systems prompted the authors to conduct studies of observer variability and to attempt to identify sources of inconsistency. Observers graded 15 patients by both the Hunt and Hess and Nishioka systems. Considerable observer variability was found, with up to four different grades being selected for the same patient. Kappa statistics were used to evaluate the data. This method determines observer agreement occurring in excess of chance. Kappa values for each grading system showed observer agreement to be significantly better than chance, yet revealed marked observer variation. Most variation occurred when Grade 3 was selected, irrespective of the system used. In a further study where observers graded clinical summaries, similar variation occurred; therefore, inconsistency was due mainly to difficulty in matching patients with levels described in the grading system, rather than to fluctuation in the patient's clinical condition or difference in the observers' examination technique. Variability was high when patients with systemic disease or vasospasm on angiography were graded with the Hunt and Hess system. The studies show that a simpler and more reliable grading system is required, and emphasize and need for caution when interpreting the results from different published series.

Entities:  

Mesh:

Year:  1982        PMID: 7069473     DOI: 10.3171/jns.1982.56.5.0628

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Treatment of subarachnoid hemorrhage with human albumin: ALISAH study. Rationale and design.

Authors:  Jose I Suarez; Renee H Martin
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

2.  Editorial: grading and decision-making in (aneurysmal) subarachnoid haemorrhage.

Authors:  J J Mooij
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

3.  Intracerebral hematomas caused by aneurysm rupture. Experience with 67 cases.

Authors:  G Nowak; D Schwachenwald; R Schwachenwald; U Kehler; H Müller; H Arnold
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

4.  Assessment of responsiveness in acute cerebral disorders. A multicentre study on the reaction level scale (RLS 85).

Authors:  D Stålhammar; J E Starmark; E Holmgren; N Eriksson; C H Nordström; O Fedders; B Rosander
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

5.  Long-term domain-specific improvement following poor grade aneurysmal subarachnoid hemorrhage.

Authors:  J Mocco; Evan R Ransom; Ricardo J Komotar; Paulina B Sergot; Noeleen Ostapkovich; J Michael Schmidt; Kurt T Kreiter; Stephan A Mayer; E Sander Connolly
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

6.  Management of subarachnoid haemorrhage.

Authors:  M Vermeulen; G J Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

7.  Level of consciousness and age as prognostic factors in aneurysmal SAH.

Authors:  R Deruty; I Pelissou-Guyotat; C Mottolese; D Amat; L Bognar
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

8.  Observer variability in assessment of angiographic vasospasm after aneurysmal subarachnoid haemorrhage.

Authors:  V Eskesen; A Karle; A Kruse; C Kruse-Larsen; J Praestholm; K Schmidt
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

9.  The future role of neurosurgery in the case of vascular diseases of the central nervous system.

Authors:  H W Pia
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

10.  Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements.

Authors:  K F Lindegaard; H Nornes; S J Bakke; W Sorteberg; P Nakstad
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.